Christopher Morten

Yale Law School

127 Wall Street

New Haven, CT 06510

United States

http://law.yale.edu/ghjp/who-we-are

Columbia Law School

435 West 116th St

NEW YORK, NY 10027

http://www.law.columbia.edu/faculty/christopher-morten

SCHOLARLY PAPERS

9

DOWNLOADS

591

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (9)

1.

Who’s Afraid of Section 1498? A Case for Government Patent Use in Pandemics and Other National Crises

23 Yale J.L. & Tech. 1 (2020)
Number of pages: 96 Posted: 03 Sep 2020 Last Revised: 12 Feb 2021
Christopher Morten, Christopher Morten and Charles Duan
Columbia Law SchoolYale Law School and American University - Program on Information Justice and Intellectual Property
Downloads 259 (149,093)
Citation 1

Abstract:

Loading...

COVID-19, pandemic, emergency, patents, drugs, medicines, vaccines, pharmaceuticals, pharma, compulsory licensing, 1498, government patent use

2.

The Big Data Regulator, Rebooted: Why and How the FDA Can and Should Disclose Confidential Data on Prescription Drugs and Vaccines

109 Calif. L. Rev. 493 (2021), Yale Law School, Public Law Research Paper Forthcoming
Number of pages: 66 Posted: 29 Sep 2020 Last Revised: 16 Jun 2021
Christopher Morten, Christopher Morten and Amy Kapczynski
Columbia Law SchoolYale Law School and Yale University - Law School
Downloads 211 (181,717)

Abstract:

Loading...

3.

U.S. 10,960,070: The U.S. Government’s Important New Coronavirus Vaccine Patent

NYU Law Technology Law & Policy Clinic Report on U.S. Patent No. 10,960,070
Number of pages: 54 Posted: 17 Aug 2021
Christopher Morten, Christopher Morten, Laurel Boman, Joseph Rabinovitsj and Celine Rohr
Columbia Law SchoolYale Law School, New York University (NYU), School of Law, New York University (NYU), School of Law and New York University (NYU), School of Law
Downloads 53 (467,062)

Abstract:

Loading...

4.

§ 1498: A Guide to Government Patent Use, a Path to Licensing and Distributing Generic Drugs

Number of pages: 46 Posted: 20 Jul 2021
Joseph Adamczyk, Adrienne Lewis, Shivani Morrison, Christopher Morten and Christopher Morten
New York University (NYU), School of Law, New York University (NYU), School of Law, New York University (NYU), School of Law and Columbia Law SchoolYale Law School
Downloads 30 (576,073)

Abstract:

Loading...

5.

The U.S. Government's Apparent Co-Ownership of Patents Protecting Remdesivir

Number of pages: 21 Posted: 28 Jul 2021
James Krellenstein, Christopher Morten and Christopher Morten
PrEP4All, Inc. and Columbia Law SchoolYale Law School
Downloads 16 (670,729)

Abstract:

Loading...

6.

Clinical Trial Cost Transparency at the National Institutes of Health: Law and Policy Recommendations

Engelberg Center on Innovation Law and Policy, NYU School of Law, 2020
Number of pages: 67 Posted: 04 Aug 2021
Ariella Barel, Laurel Boman, Christopher Morten and Christopher Morten
NYU Law, New York University (NYU), School of Law and Columbia Law SchoolYale Law School
Downloads 10 (717,216)

Abstract:

Loading...

7.

Standing with a Bundle of Sticks: The All Substantial Rights Doctrine in Action

Fordham Intellectual Property, Media & Entertainment Law Journal, Vol. 28 (2018)
Number of pages: 35 Posted: 19 Oct 2020
Mark Abate, Christopher Morten and Christopher Morten
affiliation not provided to SSRN and Columbia Law SchoolYale Law School
Downloads 9 (725,212)

Abstract:

Loading...

8.

Statement on CDC’s Patents for PrEP

Number of pages: 9 Posted: 27 Aug 2021
Christopher Morten and Christopher Morten
Columbia Law SchoolYale Law School
Downloads 3 (772,181)

Abstract:

Loading...

9.

The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation

47 Journal of Law, Medicine & Ethics 783 (January 19, 2020)
Posted: 19 Oct 2020 Last Revised: 03 Aug 2021
Christopher Morten, Christopher Morten, Aaron S. Kesselheim and Joseph Ross
Columbia Law SchoolYale Law School, Brigham and Women's Hospital/Harvard Medical School and Yale University

Abstract:

Loading...